Bluejay Diagnostics (BJDX) Current Taxes (2025 - 2026)

Bluejay Diagnostics' (BJDX) quarterly Current Taxes came in at $40000.0 in Q1 2026, down 67.1% year-on-year from $121568.0 in Q1 2025, and down 70.62% quarter-over-quarter from $136149.0 in Q4 2025.

Bluejay Diagnostics (BJDX) Current Taxes (2025 - 2026) Analysis & Trends

Bluejay Diagnostics has disclosed Current Taxes across 2 years of filings, most recently posting $40000.0 for Q1 2026.

  • Current Taxes for Q1 2026 came in at $40000.0, down 67.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $40000.0 (down 67.1% YoY), and the FY2025 annual result was $136149.0, changed N/A from the prior year.
  • Current Taxes came in at $40000.0 for Q1 2026 at Bluejay Diagnostics, down from $136149.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $136149.0 in Q4 2025 to a low of $40000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 598.00 Mn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 476.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 650.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 231.81 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 28.60 Mn
10 Bluejay Diagnostics 4.43 Mn 746,549.00 - 40,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 40,000.00
Dec 31, 2025 136,149.00
Sep 30, 2025 68,074.00
Jun 30, 2025 68,074.00
Mar 31, 2025 121,568.00